Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator

Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRα and β Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis N-Acylthiadiazolines, a New Class of Liver X Receptor Agonists with Selectivity for LXRβ Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRβ Discovery of Phenyl Acetic Acid Substituted Quinolines as Novel Liver X Receptor Agonists for the Treatment of Atherosclerosis